Sapropterin dihydrochloride 100 mg Powder for Oral Solution
RxNorm 1111018
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1111018 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sapropterin dihydrochloride 100 mg Powder for Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Sapropterin dihydrochloride 100 mg Powder for Oral Solution
(Atom ID: 12350128)
PSNPrescribable
Prescribable Name (PSN):
Sapropterin dihydrochloride 100 mg Powder for Oral Solution
(Atom ID: 7244826)
Patient Education
Sapropterin
Sapropterin is used along with a restricted diet to control blood phenylalanine levels in adults and children 1 month of age and older who have phenylketonuria (PKU; an inborn condition in which phenylalanine may build up in the blood and causes decreased intelligence and a decreased ability to focus, remember, and organize information). Sapropterin will only work for some people who have PKU, and the only way to tell if sapropterin will help a particular patient is to give the medication for a period of time and see whether his or her phenylalanine level decreases. Sapropterin is in a class of medications called cofactors. It works by helping the body to break down phenylalanine so it will not build up in the blood.
[Learn More]
* Please review the disclaimer below.